跳至主要内容
临床试验/NCT06880224
NCT06880224招募中不适用

Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness/Implementation Hybrid Study: Aim 2

Northwestern University6 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2025年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
500
试验地点
6
主要终点
Case Finding: HIV-positive serostatus

研究概览

简要总结

Two combination interventions (HIV Case Finding Intervention and HIV Treatment Intervention), each with mHealth and Peer Navigation components, will be evaluated in two 48-week parallel hybrid effectiveness/implementation trials among youth aged 15-24 in Nigeria.

详细描述

Two combination interventions, each with mHealth and Peer Navigation components, will be evaluated in two 48-week parallel hybrid effectiveness/implementation trials among youth aged 15-24 in Nigeria:

  1. HIV Case Finding Intervention: single arm trial of an HIV case finding and linkage to care intervention targeting young men at risk of HIV infection (n = 6000), particularly young men who have sex with men (YMSM) in Akwa Ibom, Benue, Enugu, Kano, Taraba, and Lagos states who complete HIV testing.

Objectives: To determine the effectiveness of the intervention to:

  • identify youth living with HIV, particularly YMSM and
  • link those who test HIV-positive to HIV care
  • pre-exposure prophylaxis (PrEP) initiation (uptake) among those who test HIV-negative.
  1. HIV Treatment Intervention: randomized controlled trial of a medication adherence and viral suppression intervention among youth newly diagnosed with HIV and initiating antiretroviral therapy (ART) for the first time (n = 600) at the participating clinical sites.

Objectives: To determine the effectiveness of the intervention on

  • viral suppression and
  • adherence to ART
  • success of implementation in the target populations

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
15 Years 至 24 Years(Child, Adult)
性别
All
接受健康志愿者
是

入选标准

  • •HIV Case Finding Intervention:
  • •Aged 15 to 24
  • •Male birth sex of any current gender identity
  • •Understand basic English, Yoruba, Hausa, Igbo or Pidgin English For the PrEP component, must also be HIV-negative
  • •HIV Treatment Intervention:
  • •Aged 15 to 24
  • •HIV seropositive
  • •Initiating ART for the first time at a Clinical Research Performance Site (CRPS) clinic or satellite clinic
  • •Understand basic English, Yoruba, Hausa, Igbo or Pidgin English
  • •Intention to remain a CRPS patient during follow-up

排除标准

  • •Unable to provide consent
  • •No parental permission if aged 15 and not emancipated

研究组 & 干预措施

HIV Case Finding Intervention

Experimental

Combination HIV case finding and linkage to care intervention

干预措施: Testing Peer navigation (Behavioral)

HIV Case Finding Intervention

Experimental

Combination HIV case finding and linkage to care intervention

干预措施: PrEP Intervention (Behavioral)

HIV Case Finding Intervention

Experimental

Combination HIV case finding and linkage to care intervention

干预措施: Social Media Outreach (Behavioral)

HIV Treatment Intervention

Experimental

Combination HIV treatment intervention vs. standard of care adherence among youth newly diagnosed with HIV and initiating ART

干预措施: Treatment Peer Navigation (Behavioral)

HIV Treatment Intervention

Experimental

Combination HIV treatment intervention vs. standard of care adherence among youth newly diagnosed with HIV and initiating ART

干预措施: SMS Test messaging (Behavioral)

HIV Treatment Intervention

Experimental

Combination HIV treatment intervention vs. standard of care adherence among youth newly diagnosed with HIV and initiating ART

干预措施: Adherence standard of care (Other)

结局指标

主要结局

Case Finding: HIV-positive serostatus

时间窗: 48 weeks

HIV-positive serostatus based on rapid test with confirmation

Treatment: Viral suppression

时间窗: 48 Weeks

Viral suppression (\< 200 copies per mL)

次要结局

  • Case Finding: Linkage to HIV care(48 Weeks)
  • Case Finding: PrEP among youth who test HIV-negative(48 weeks)
  • Treatment: Adherence to antiretroviral therapy (ART)(48 Weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Garofalo

Professor

Northwestern University

研究点 (6)

Loading locations...

相似试验